These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 17171)

  • 1. [Results of clinical studies of beta stimulating agents in the treatment of chronic heart disease].
    Metelutsa VI; Chazova LV; Grigor'iants RA; Krol VA; Trubetskoĭ AV
    Ter Arkh; 1977; 49(4):44-8. PubMed ID: 17171
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of beta-blocking agents and beta stimulators on the intracardiac hemodynamics and myocardial contraction in ischemic heart disease].
    At'kov OIu; Krol VA; Chumburidze VB
    Ter Arkh; 1977; 49(10):57-60. PubMed ID: 22937
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic value of oxyphedrin (Ildamen) in treatment of ischemic heart disease].
    Giec L; Mandecki T; Hermanowicz A
    Wiad Lek; 1973 Dec; 26(23):2201-5. PubMed ID: 4148957
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of the sympathomimetic activity of beta-adrenergic blockaders in the treatment of patients with chronic ischemic heart disease].
    Ol'binskaia LI; Bragina GI
    Ter Arkh; 1983; 55(9):35-40. PubMed ID: 6138864
    [No Abstract]   [Full Text] [Related]  

  • 5. [The clinical pharmacology of a new specific adrenergic beta bronchodilator].
    Curti PC
    Int J Clin Pharmacol; 1974 Jun; 9(4):305-13. PubMed ID: 4153546
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stimulators of beta-adrenergic structures in treatment of ischemic heart disease].
    Komarov FI; Ol'binskaia LI; Abinder AA; Iankin VV; Kitaeva IT
    Kardiologiia; 1975 Jul; 15(7):37-43. PubMed ID: 1568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in intracardiac hemodynamics and the tolerance for physical loading as affected by Nitrong in persons suffering from ischemic heart disease].
    Gasilin VS; Shevchenko OP; Maksumov EIu; Lupanov VP
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):59-64. PubMed ID: 6789850
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of potassium-magnesium aspartate on hemodynamics and myocardial metabolism of coronary disease patient during beta receptor stimulation].
    Kühn P; Probst P
    Z Kardiol; 1975 Jul; 64(7):616-24. PubMed ID: 240236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cordipine in the treatment of patients with exacerbated coronary disease].
    Musiał W; Bolińska H; Pracka H; Polak-Słaboszewska D
    Wiad Lek; 1989 Feb; 42(4):205-9. PubMed ID: 2576167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonists.
    Packer M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S38-43. PubMed ID: 2478808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical observations of using nifedipine in coronary disease].
    Goch JH; Adamska-Dyniewska H; Tkaczewski W; Brzozowski R; Dziekański S; Rosiek S; Kruszyński G
    Kardiol Pol; 1987; 30 Suppl():54-60. PubMed ID: 3331400
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of naftidrofuryl (Dusodril) on central hemodynamics and respiration].
    Reiterer W
    Wien Med Wochenschr; 1975 Nov; 125(46):663-6. PubMed ID: 779282
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of the action of dobutamine in acute cardiac insufficiency].
    Chevalier P; Leylavergne J; Gournay G; Laffay N; Gryman R; Renault C; Guérot C; Valère PE; Tricot R
    Ann Cardiol Angeiol (Paris); 1984; 33(4):227-32. PubMed ID: 6147116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isosorbide dinitrate spray: a comparative pharmacodynamic study with a sublingual preparation in patients with chronic cardiac insufficiency].
    Marchionni N; Di Bari M; Ferrucci L; Moschi G; Paoletti M; Salani B; Boncinelli L; Fumagalli S; Schneeweiss A
    Cardiologia; 1988 May; 33(5):505-9. PubMed ID: 3048661
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ergometric study of the association of a beta-blocker and a nitrate derivative].
    Jullien G
    Nouv Presse Med; 1978 Sep; 7(31):2727-31. PubMed ID: 30951
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical impressions of a new beta-adrenergic blocking drug, 39,089-Ba.
    Wilson DF; Turner AS
    N Z Med J; 1967 Oct; 66(422):682-3. PubMed ID: 4864443
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fendiline hydrochloride as a therapeutic agent in chronic coronary insufficiency].
    Vichi FL
    Arq Bras Cardiol; 1980 Apr; 34(4):327-30. PubMed ID: 7002122
    [No Abstract]   [Full Text] [Related]  

  • 18. [Possibilities and limitations of selective beta 1 adrenergic receptor blockade in clinical practice].
    Ol'binskaia LI; Vartanova OA; Sinopal'nikov AI; Alekseev VG; Logunov OV
    Ter Arkh; 1988; 60(8):31-4. PubMed ID: 3067409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of different groups of adrenergic beta receptor blockaders on the clinical course of the disease, work capacity and echocardiographic indicators in ischemic heart disease].
    Komarov FI; Ol'binskaia LI; Bragina GI
    Ter Arkh; 1979; 51(8):13-7. PubMed ID: 41333
    [No Abstract]   [Full Text] [Related]  

  • 20. [Stimulation, stimulus conduction and myocardial excitability of the human heart under oxyfedrin therapy of bradycardic dysrhythmias (author's transl)].
    Diewitz M
    Med Klin; 1974 May; 69(18):806-13. PubMed ID: 4151986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.